An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)

NCT02365623 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis, Multidrug-Resistant

Interventions

DRUG: TMC207 (bedaquiline)
DRUG: Background Regimen (BR)

Sponsor

Janssen Pharmaceutical K.K.